Clover Health Investments announced that the Centers for Medicare & Medicaid Services awarded its PPO Medicare Advantage plans a 5 Star rating and its HMO Medicare Advantage plan a 4.5 Star rating for 2027, affecting payment year 2028. The 5 Star rating means Clover's PPO plans can enroll beneficiaries year round, and the company said it grew Medicare Advantage membership roughly 48% year-over-year through the first half of 2026 to more than 157,000 members, with about 98% enrolled in its wide-network PPO plans. CMS calculated the PPO rating by removing the 20 measures at issue in Clover Insurance Company v. Department of Health & Human Services, a May 27, 2026 decision now on appeal; with those measures included, the PPO plans would have received 4.5 Stars. Clover also reported a HEDIS score of 4.82 out of 5 Stars for the third straight year, ranking first among non-SNP PPO plans with over 2,000 members, unchanged under either CMS methodology. CEO Andrew Toy said the rating strengthens Clover's ability to support members and provide market-leading plans, while Medicare Advantage CEO Jamie Reynoso said the company can reinvest in more competitive benefits.
Clover Health Investments CorpCMS awarded Clover's PPO Medicare Advantage plans a 5 Star rating for 2027, enabling year-round enrollment and stronger positioning.
